North America Dietary Supplements Market By Product (Tablets & Capsules, Powder System, Liquids, Soft Gels), Ingredients (Vitamins & Minerals, Botanicals, Amino Acids, Enzymes & Others), End User (Adults, Children, Infants & Old Aged, Pregnant Woman)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the North America Dietary Supplements Market
Market Report Description
The North America Dietary Supplements Market would witness market growth of 9.7% CAGR during the forecast period (2017-2023). Multivitamin are majorly added as dietary supplements, which are consumed for a healthy lifestyle and addressing nutrition deficiencies on a daily basis. Easy availability of sports nutrition products in supermarkets and convenience stores would drive the market demand. Awareness about functional foods to remain healthy and reduce the risk of cholesterol related diseases would significantly add to the Dietary Supplements market. However, the introduction of new nutraceutical products such as yogurt, fresh bread, cereal bars and frozen baked foods are the factors that would limit the market expansion.
Based on Product, the Dietary Supplements market segments the market intoTABLEts & Capsules, Powder, Liquids, Soft Gels, and Others. Based on Ingredients, the market report segments the market into Vitamins & Minerals, Botanicals, Amino Acids, and Enzymes & Others. Based on End User, the Dietary Supplements market segments the market into Adults, Children, Infants & Old Aged, and Pregnant Woman. Based on Regions, the Dietary Supplements market segments the market into US, Mexico, Canada, and Rest of North America. The market research report covers the analysis of key stake holders of the North America Dietary Supplements Market.
Key companies profiled in the report include Abbott Laboratories, The Carlyle Group, GlaxoSmithKline plc, Alticor (Amway), Glanbia, Plc. (Glanbia Nutritionals), Bayer AG, Archer Daniels Midland Company, E. I. Du Pont De Nemours and Company, Nutraceutics Inc., and Pfizer, Inc.